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SUMMARY
Sixtypatientspresentingforin-patientgynaecological laparoscopicsurgerywererandomlyallocated
to receive either diclofenac 75mg (n=20), ketorolac 30mg (n=20) or piroxicam 20mg (n=20) as an
intra-muscular injection immediately after induction ofanaesthesia. Postoperative visual analogue
scores over the first 24 hours, using a 10cm scale, ranged from 3.2-0.5 in the diclofenac group, 2.7-
0.85intheketorolacgroupand2.8-0.5inthepiroxicamgroup.Thescoresdidnotdiffersignifilcantly
between the three groups (p>0.05). Mean time (SD) to first analgesia was 27(94) minutes in the
piroxicam group, 16 (30) minutes in the diclofenac group and 62 (120) minutes in the piroxicam
group.Sixoutoftwentypatientsinthediclofenacgrouprequiredfurtheranalgesiacomparedtonine
outoftwentyintheothertwodruggroups.Thisdifferencewasnotsignificant.Therewerenoreports
of increased bleeding, bronchoconstriction, bleeding from the upper gastrointestinal tract, renal
impairment or pain from the intra-muscular injection site in any ofthe groups. The administration
ofa non-steroidal anti-inflammatory drug to patients presenting for laparoscopic surgery reduces
postoperative pain. There were no obvious differences between the agents used.
INTRODUCTION
Non-steroidal anti-inflammatory drugs [NSAIDS]
are useful adjuncts to opioids for postoperative
analgesia.' NSAIDS canprovide similaranalgesia
to the opioids,2 but avoid the sedation, respiratory
depression, nausea and vomiting caused by them.
Many workers have shown that both diclofenac
and ketorolac can reduce opioid requirements
following major gynaecological and upper
abdominal surgery.3 4'5 Diclofenac can provide
similar analgesia to fentanyl following knee
arthroscopy.6 Unfortunately intramuscularly
administered diclofenac has been associated with
muscledamage,7 anddue to increasedreporting of
severe bleeding and renal impairment, especially
in the elderly8 the recommended dose ofketorolac
has been reduced to a maximum daily dosage of
30mg.
Wecomparedtheanalgesic efficacy andincidence
of side-effects of diclofenac, ketorolac and
piroxicam, given intramuscularly after induction
of anaesthesia, in patients undergoing inpatient
gynaecological laparoscopic surgery.
METHODS
The study protocol was approved by the Regional
Medical Ethics Committee and written informed
consentwasobtainedfrom60ASA 1-2(iepatients
who are healthy or have a mild systemic illness)
female patients scheduled for either in-patient
diagnosticlaparoscopyorlaparoscopicsterilisation.
Patients with a history of upper gastrointestinal
symptoms, known hypersensitivity to the study
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drugs, impaired renal function, asthma or on
medication likely tointerferewiththestudyresults
were excluded. We explained the use ofthe visual
analogue scale (VAS) 0-10 at the preoperative
visit. (The VAS was 10cm in length with 0 at the
leftend, representing "no pain" and 10 at the right
end scoring "the worst pain imaginable").
Patients were premedicated with lorazepam 2mg
by mouth 2 hours before surgery. Anaesthesia was
induced with propofol 2mg/kg and fentanyl Imcg/
kg. Atracurium 0.5mg/kg was given to facilitate
tracheal intubation and intraoperative ventilation.
Anaesthesiawasmaintainedwith 1-1.5%isoflurane
in 65% nitrous oxide in oxygen. At the end ofthe
procedure neuromuscular blockade was reversed
withneostigmine2.5mgandglycopyrrolate0.5mg.
Following induction the patients were randomly
allocated to receive a 3ml deep intra-muscular
injection in the lateral compartment of the right
thighofeitherdiclofenac75mg(groupD),ketorolac
30mg (group K ) or piroxicam 20mg (group P).
Thepatients' age,height,andweightwererecorded,
and the interval from the end of surgery until the
firstrequestforanalgesiawasnoted. Postoperative
analgesia was prescribed in the form of either
paracetamol lg orintra-muscular 'Cyclimorph 10'
0.01 ml/kg. Thiswasadministeredtothepatientby
therecovery wardnurses who wereunaware ofthe
study drug given. Oral analgesiawas administered
ifthe patient's pain score was 3 orgreater and and
cyclimorph was given if the pain score was 5 or
greater. The dose and timing ofany postoperative
analgesiawasnoted.PatientscompletedtheirVAS
scores for pain on movement at the following
times: on admission to recovery ward, at 1 hour, 2
hours, 4 hours and 24 hours after completion of
surgery. They were also asked about the presence
ofmusculoskeletal pain andpain from the NSAID
injection site.
For statistical analysis we used an independent
samples Student's t-test for continuous variables,
the Kruskal-Wallis test for VAS scores and Chi-
squareforcategorical samples. APvalueof<0.05
was considered statistically significant.
RESULTS
Datawereobtainedfrom60patients andtreatment
groupsweresimilarinrespectofage,height,weight
and nature of surgery. There was no difference in
the dosages of propofol or fentanyl between the
three groups (Table I).
TheVASpainscores(TableII)inthethreedifferent
groups were not significantly different at any time
in the 24 hour postoperative study period. Median
(Interquartile range) VAS scores (Table II) in the
study groups were diclofenac 2.1(2.6), ketorolac
2.1(2.7) and piroxicam 2.3(2.5). The mean (SD)
intervalstofirstanalgesia(TableII)were27(93.7),
16.3(30.2) and 62(120) minutes in the diclofenac,
ketorolac and piroxicam groups respectively
(p>0.05), althoughthetimetofirstanalgesiaseems
longer in the piroxicam group the results were
skewed by one patient who required cyclimorph
420 minutes after surgery. Six patients in the
diclofenac group, nine in the ketorolac group and
nine in the piroxicam group required further
analgesiaintheformofasingleopioidintramuscular
injection, but this difference was not statistically
significant. Ofthetwentyfourpatientswhoreceived
an intra-muscular opioid, six patients received co-
codamolinitially,butthisdidnotprovidesufficient
analgesia.
DISCUSSION
The NSAIDS can reduce postoperative pain by
central andperipheralcyclooxygenase inhibition.9
This has led to theiruse as single analgesics'0 orin
combination with opioids. Prostaglandins are
present in menstrual fluid, and the NSAIDS can
reduce the pain associated with menstruation."
Similarly they might be expected to reduce pain
aftersurgicalmanipulationoftheFallopiantubes.'2
Piroxicam is an oxicam and not related to
acetylsalicylic acid. Ithas different characteristics
from other NSAIDS such as a longer half-life (30
hours).13 This is due to extensive protein binding
allowingaoncedailydosagewhichshouldprovide
longer duration analgesia compared to the other
NSAIDS.'4 Previous studies have demonstrated
that piroxicam, in oral and intramuscular
formulationsissuperiortoplaceboandotherwidely
used NSAIDS in providing analgesia. In dental
patients oral piroxicam 20mg was shown to be
superiorto50mgdiclofenac, andinasimilargroup
ofpatients there wasno differencebetween 50 and
100mg of diclofenac.'5 In arthroscopy patients
Morrow et al'6 showed 30mg of ketorolac to be
clinically superior to 75mg diclofenac. When
piroxicam was compared with other commonly
used NSAIDS in patients with osteoarthritis it
showed good clinical efficacy and as there were
fewerreportedside-effectsitwasthoughtgenerally
more tolerable.'4' 17, 18
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TABLE I
Physical characteristics in the treatment groups shown. Values are mean. Standard deviation shown in
brackets.
Diclofenac Ketorolac Piroxicam
(n=20) (n=20) (n=20)
Age: years 34 (7.7) 30 (6.1) 31 (7.88)
Height: cm 156 (7.2) 157 (7.2) 155 (6.8)
Weight: kg 68 (6.7) 62 (8.8) 61 (6.2)
Laparoscopic sterilization: 6 6 6
Diagnostic laparoscopy: 14 14 14
Propofol dose: mg 155 (30) 153 (30) 156 (26)
Fentanyl dose: mcg 74(14) 70(15) 74(16)
TABLE II
Median (interquartile range) VAS scores over thefirst 24 hours after surgery and mean (SD) time to
first analgesia.
Diclofenac Ketorolac Piroxicam
(n=20) (n=20) (n=20)
Median VAS scores 2.1 (2.6) 2.1 (2.7) 2.3 (2.5)
Time to first analgesia
(minites) 27 (93.7) 16 (30.1) 62 (120)
However there was no difference in VAS scores
betweenthethreestudygroupspostoperativelybut
there was adifference in the time to firstanalgesia
in the ketorolac group compared to the diclofenac
and piroxicam groups. In the latter two groups
there were patients requesting analgesia 360-420
minutes after surgery as compared to 130 minutes
in the ketorolac group. Although not statistically
significant, due to the small number, it would
suggest that diclofenac and piroxicam may have a
longereffectthanketorolac. BygivingtheNSAID
togynaecologicallaparoscopypatientsthenumber
of patients requiring postoperative analgesia was
reduced, and most patients reported adequate
analgesia. Despitethelongerhalf-lifeofpiroxicam,
allthreedrugsproducedsimilarresults, suggesting
thereduction inpostoperative pain occurredinthe
immediateperioperativeperiod.Preoperativenerve
blocksinpatientsundergoinginguinalherniarepair
have been shown to provide better postoperative
analgesiathanpostoperativenerveblockade.19The
preoperative reduction of the inflammatory
responsebytheNSAIDS providedthepatientwith
good analgesia. However is immediately post
inductionthemostbeneficialtimeofadministration
ofNSAIDS? More workis required to answerthis
question.
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